Loading...
Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib
Sorafenib remains the standard care for patients with hepatocellular carcinoma (HCC) even though it has low antitumor efficacy. Protein neddylation is abnormally activated in many types of human cancer. However, whether dysregulation of neddylation is involved in HCC progression and whether targetin...
Na minha lista:
| Udgivet i: | Oncol Rep |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6489087/ https://ncbi.nlm.nih.gov/pubmed/31002342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2019.7098 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|